AS1411 is a DNA aptamer targeting nucleolin, and is now in clinical trials on advanced solid tumors and acute myeloid leukemia (NCT00512083 phase II, completed; NCT00881244 phase I, completed). The gene discussed is NUCLEOLIN; the disease is acute myeloid leukemia.